FORCE's XRAYS program, funded by the CDC, is a reliable resource for young breast cancer survivors and high-risk women to navigate through breast cancer research related news and information.
Breast cancer survivors
Women under 45
Women over 45
Men with breast cancer
Metastatic breast cancer
Triple negative breast cancer
BRCA mutation carriers
Her2+ breast cancer
Finding new treatments that target triple-negative breast cancer is an area of great interest. An early step in developing these treatments is learning more about the biology of tumor in the laboratory. This study looked at how capsaicin, the spicy component of chili peppers, might work with a protein found in many cancers, including triple-negative breast cancer, to stop cancer cell growth. This is the first step in a long process towards developing new treatments for triple-negative breast cancer. (2/14/17)
Early research showing potential ways to stop triple-negative breast cancer cells from growing in the laboratory.
Preliminary laboratory studies like these are important because they help researchers to understand how breast cancer cells differ from normal cells and to identify new drugs to treat the cancer.
This is very early research that could lead to new treatments. Laboratory studies like this one must be confirmed by more research and then tested in patients through clinical trials before they become part of recommended treatment. This study does not mean that chili peppers prevent or help treat cancer.
While this study is not ready for clinical trials, many open trials are studying ways to treat all stages of triple-negative breast cancer. For now, patients with triple-negative breast cancer should talk to their health care providers about treatment options and discuss whether or not a clinical trial is a good option. In addition, all women with triple-negative breast cancer before age 60 meet national guidelines for genetic counseling and testing for mutations in BRCA or other genes that increase cancer risk.
Medical News Today
Daily Mail UK
The TRPV1 protein detects harmful heat and helps pathways in your body to control pain relating to temperature changes. Extremely hot temperatures, acidic conditions and capsaicin, the spicy component of chili peppers, activate TRPV1. Previous researchers found that TRPV1 is involved in the growth of cancers, such as colon and pancreatic. However, it has not been studied as much in breast cancer, and its role in all of these cancers is not well understood.
Lea Weber and colleagues from Ruhr University Bochum and other institutions published work in the journal Breast Cancer: Targets and Therapy in December 2016 to try and understand if and how TRPV1 protein is involved in breast cancer.
Is TRPV1 involved in breast cancer?
This study included tumors from 11 different breast cancer patients and 49 different types of breast cancer cells grown in the laboratory.
While these findings are interesting, they come from a very early research study. The capsaicin treatment was used on cells grown in the laboratory, not on mice or humans. More work is needed to find out if this treatment works in animal models of breast cancer before it can be tested for human safety and effectiveness. At this time, we do not know if the lab response would be duplicated in human breast cancer patients.
It is also critical to understand that this experiment used pure capsaicin, the spicy component of chili peppers, which was likely much stronger than one would consume by eating chili peppers. The research does not show if consuming chili peppers would have any effect. This means that this study does not identify capsaicin as an ingredient to help people lower their breast cancer risk, treat breast cancer, or help prevent recurrence.
This research is an early study that suggests the TRPV1 protein may play a role in breast cancer, especially triple-negative breast cancer, because it was found in all of the breast cancer cells grown in the laboratory and from patient tumor samples. It also showed that adding capsaicin, the spicy component of chili peppers, helped stop the triple-negative breast cancer cells from growing. However, because this is very early research done in cells grown in the laboratory, much more work needs to be done before this can be applied in a health care setting. Women interested in participating in trials looking at new treatments for breast cancer are encouraged to ask their health care providers about clinical trials or visit the Research section of the FORCE website.
Reports of this research have been widely shared on social media. Snopes, a website that validates or debunks news stories, has also stated that the claim that “capsaicin, the spice-causing molecule in chili peppers, can help beat breast cancer,” is unproven.
Share your thoughts on this XRAYS article by taking our brief survey
Weber LV, Al-Refae K, Wolk G, et al. “Expression and functionality of TRPV1 in breast cancer cells.” Breast Cancer: Targets and Therapy, Volume 8 (2016): 243-252.
“Capsaicin Application.” Snopes.com.
FORCE Information: Breast Cancer Treatment
FORCE Information: Participating in Research
Be Empowered Webinar: Newly Diagnosed with Breast Cancer: What You Need to Know
FORCE Research Update: Carboplatin effective in treating triple negative breast cancer in BRCA mutation carriers